From ASCO-targeted therapies: Anti-PD-1 approaches--important steps forward in metastatic melanoma

Nat Rev Clin Oncol. 2013 Jul;10(7):365. doi: 10.1038/nrclinonc.2013.98. Epub 2013 Jun 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • CTLA-4 Antigen / antagonists & inhibitors*
  • Female
  • Humans
  • Male
  • Melanoma / drug therapy*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Skin Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • CTLA-4 Antigen
  • Programmed Cell Death 1 Receptor